Thousands of testicular cancer survivors join study to perfect relapse detection
NCT ID NCT02229916
First seen Jan 14, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study follows about 6,900 men who have finished treatment for testicular cancer to find the best way to detect if the cancer comes back. Researchers will compare different tests like CT scans, blood tests, and physical exams to see which ones work best. The study also tracks long-term side effects of treatment, such as heart problems and hearing loss, to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TESTICULAR NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kantonsspital St.Gallen; Onkologie/Haematologie
RECRUITINGSankt Gallen, 9007, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.